The company has 21 subsidiaries and more than 11000 employees. Its main business covers new drug research and development, preparation production, drug sales, pharmaceutical equipment and API production. It has rich product lines, high-quality product quality, strong channel and terminal coverage and management capabilities, good brand advantages and international advantages The company has a profound corporate culture, a dynamic talent team, economic strength, competitive vitality and sustainable development ability.
The company actively laid out four business platforms of generic medicine business, infusion business, differentiated medicine business and innovative medicine business, and deeply cultivated the fields of chronic disease, infusion, pediatrics, nephrology, and spirit/nerve. The annual sales of 19 key products, such as No. 0, Guanshuang, Lashida, Suiyue, Tangshiping, BFS infusion, Kelisu, peritoneal dialysis fluid, magnesium valproate sustained-release tablets, exceeded 100 million yuan.